From: Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma
Covariate | Beta coefficient | Hazard ratio | 95% CI | p |
---|---|---|---|---|
Age | -0.037* | -** | - | 0.154 |
Age’ | 0.089* | -** | - | 0.013 |
Size | 0.006† | -†† | - | 0.095 |
Size’ | -0.004† | -†† | - | 0.359 |
Favorable site | -0.204 | 0.82 | 0.65-1.02 | 0.076 |
Stage | ||||
Regional | 0.404 | 1.50 | 1.13-1.98 | 0.004 |
Distant | 1.259 | 3.52 | 2.64-4.70 | <0.001 |
Histology | ||||
Alveolar | 0.497 | 1.64 | 1.35-2.00 | <0.001 |
Other | -0.135 | 0.87 | 0.59-1.29 | 0.499 |
Received surgery | -0.612 | 0.54 | 0.40-0.72 | <0.001 |
Received RT | -0.632 | 0.53 | 0.42-0.68 | <0.001 |
Interaction terms | ||||
Surgery × RT | 0.564 | 1.75 | 1.24-2.50 | 0.002 |